Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Value of Thrombelastogralhy to Pre-operatively Predict Hip Fracture Patients at Risk of Major Blood Loss During and After Surgery.

NCT02297061 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT02297061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02297061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Value of Thrombelastogralhy to Pre-operatively Predict Hip Fracture Patients at Risk of Major Blood Loss During and After Surgery.
Lead sponsor
Hvidovre University Hospital
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
August 31, 2014
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, hip fracture